This latest funding round comes about a year after ElevateBio announced a $170 million Series B. The money will be used to expand its R&D and manufacturing capabilities, and spin out new companies and partnerships based on that research.
Embark’s tests can be used to help determine over 200 genetic health risks for your dog. After a test is complete, pet owners can create personalized care plans for their dogs based on their genetic profile.
This new partnership between Amwell and Google Cloud marks a major shift in the healthcare industry, which has become increasingly reliant on telehealth thanks to the COVID-19 pandemic.